Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Asia Pacific Viral Vector Production Market Size, Share & Trends Analysis Report By Type (Adeno-Associated Viral Vectors, Lentiviral Vectors, Adenoviral Vectors, Retroviral Vectors, and Others), By Indication, By Application, By Country and Growth Forecast, 2023 - 2030

Published Date : 25-Jan-2024

Pages: 117

Formats: PDF

The Asia Pacific Viral Vector Production Market would witness market growth of 20.3% CAGR during the forecast period (2023-2030).

The extensive pipeline of gene therapy and viral vaccines presents a promising outlook for the future growth of the viral vector production market. The demand for viral vectors is set to rise as they play a critical role in facilitating the delivery and efficacy of these therapies with an expanding pipeline in various therapeutic areas. The demand for viral vector production is expected to experience a substantial upsurge as more gene therapies and viral vaccines advance through clinical trials and gain regulatory approval. This favorable scenario creates an opportunity for viral vector production companies to expand their operations and cater to the increase in requirements of the dynamic biopharmaceutical industry.

The biotechnology field has undergone a revolutionary transformation recently, with viral vectors emerging as indispensable tools for gene therapy, vaccine development, and various biomedical applications. Viral vectors, primarily derived from viruses, serve as efficient vehicles for delivering therapeutic genes or genetic material into target cells. This dynamic landscape has fueled the growth of the viral vector production market, creating new opportunities and challenges for biopharmaceutical companies, research institutions, and other stakeholders.

Various governments in the Asia Pacific region are implementing initiatives to support the biopharmaceutical industry. Incentives, grants, and supportive regulatory frameworks encourage research, development, and production activities related to viral vectors. Therefore, the factors mentioned above will propel market growth in this region.

The China market dominated the Asia Pacific Viral Vector Production Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $262.7 Million by 2030. The Japan market is registering a CAGR of 19.5% during (2023 - 2030). Additionally, The India market would witness a CAGR of 21.1% during (2023 - 2030).

Free Valuable Insights: The Global Viral Vector Production Market is Predict to reach $ 3.9 Billion by 2030, at a CAGR of 19.1%

Based on Type, the market is segmented into Adeno-Associated Viral Vectors, Lentiviral Vectors, Adenoviral Vectors, Retroviral Vectors, and Others. Based on Indication, the market is segmented into Cancer, Genetic Disorders, Infectious Diseases, and Others. Based on Application, the market is segmented into Gene Therapy, and Vaccinology. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Andelyn Biosciences, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • FinVector Oy (Ferring Ventures S/A)
  • Thermo Fisher Scientific, Inc.
  • Novartis AG
  • Takara Bio Inc. (Takara Holdings Inc.)
  • Avid Bioservices, Inc.
  • Oxford Biomedica plc
  • Lonza Group Ltd.

Asia Pacific Viral Vector Production Market Report Segmentation

By Type

  • Adeno-Associated Viral Vectors
  • Lentiviral Vectors
  • Adenoviral Vectors
  • Retroviral Vectors
  • Others

By Indication

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Others

By Application

  • Gene Therapy
  • Vaccinology

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Viral Vector Production Market, by Type
1.4.2 Asia Pacific Viral Vector Production Market, by Indication
1.4.3 Asia Pacific Viral Vector Production Market, by Application
1.4.4 Asia Pacific Viral Vector Production Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis

Chapter 4. Strategies Deployed in Viral Vector Production Market

Chapter 5. Asia Pacific Viral Vector Production Market, by Type
5.1 Asia Pacific Adeno-Associated Viral Vectors Market, by Country
5.2 Asia Pacific Lentiviral Vectors Market, by Country
5.3 Asia Pacific Adenoviral Vectors Market, by Country
5.4 Asia Pacific Retroviral Vectors Market, by Country
5.5 Asia Pacific Others Market, by Country

Chapter 6. Asia Pacific Viral Vector Production Market, by Indication
6.1 Asia Pacific Cancer Market, by Country
6.2 Asia Pacific Genetic Disorders Market, by Country
6.3 Asia Pacific Infectious Diseases Market, by Country
6.4 Asia Pacific Others Market, by Country

Chapter 7. Asia Pacific Viral Vector Production Market, by Application
7.1 Asia Pacific Gene Therapy Market, by Country
7.2 Asia Pacific Vaccinology Market, by Country

Chapter 8. Asia Pacific Viral Vector Production Market, by Country
8.1 China Viral Vector Production Market
8.1.1 China Viral Vector Production Market, by Type
8.1.2 China Viral Vector Production Market, by Indication
8.1.3 China Viral Vector Production Market, by Application
8.2 Japan Viral Vector Production Market
8.2.1 Japan Viral Vector Production Market, by Type
8.2.2 Japan Viral Vector Production Market, by Indication
8.2.3 Japan Viral Vector Production Market, by Application
8.3 India Viral Vector Production Market
8.3.1 India Viral Vector Production Market, by Type
8.3.2 India Viral Vector Production Market, by Indication
8.3.3 India Viral Vector Production Market, by Application
8.4 South Korea Viral Vector Production Market
8.4.1 South Korea Viral Vector Production Market, by Type
8.4.2 South Korea Viral Vector Production Market, by Indication
8.4.3 South Korea Viral Vector Production Market, by Application
8.5 Singapore Viral Vector Production Market
8.5.1 Singapore Viral Vector Production Market, by Type
8.5.2 Singapore Viral Vector Production Market, by Indication
8.5.3 Singapore Viral Vector Production Market, by Application
8.6 Malaysia Viral Vector Production Market
8.6.1 Malaysia Viral Vector Production Market, by Type
8.6.2 Malaysia Viral Vector Production Market, by Indication
8.6.3 Malaysia Viral Vector Production Market, by Application
8.7 Rest of Asia Pacific Viral Vector Production Market
8.7.1 Rest of Asia Pacific Viral Vector Production Market, by Type
8.7.2 Rest of Asia Pacific Viral Vector Production Market, by Indication
8.7.3 Rest of Asia Pacific Viral Vector Production Market, by Application

Chapter 9. Company Profiles
9.1 Andelyn Biosciences, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Product Launches and Product Expansions:
9.2.4.2 Acquisition and Mergers:
9.2.4.3 Geographical Expansions:
9.2.5 SWOT Analysis
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.5.2 Geographical Expansions:
9.5.6 SWOT Analysis
9.6 Novartis AG
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Recent strategies and developments:
9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis
TABLE 1 Asia Pacific Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Adeno-Associated Viral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Adeno-Associated Viral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Lentiviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Lentiviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Adenoviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Adenoviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Retroviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Retroviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Genetic Disorders Market, by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Genetic Disorders Market, by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Gene Therapy Market, by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Gene Therapy Market, by Country, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Vaccinology Market, by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Vaccinology Market, by Country, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Viral Vector Production Market, by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Viral Vector Production Market, by Country, 2023 - 2030, USD Million
TABLE 33 China Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 34 China Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 35 China Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 36 China Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 37 China Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 38 China Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 39 China Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 40 China Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 41 Japan Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 42 Japan Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 43 Japan Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 44 Japan Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 45 Japan Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 46 Japan Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 47 Japan Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 48 Japan Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 49 India Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 50 India Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 51 India Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 52 India Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 53 India Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 54 India Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 55 India Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 56 India Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 57 South Korea Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 58 South Korea Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 59 South Korea Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 60 South Korea Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 61 South Korea Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 62 South Korea Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 63 South Korea Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 64 South Korea Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 65 Singapore Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 66 Singapore Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 67 Singapore Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 68 Singapore Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 69 Singapore Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 70 Singapore Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 71 Singapore Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 72 Singapore Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 73 Malaysia Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 74 Malaysia Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 75 Malaysia Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 76 Malaysia Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 77 Malaysia Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 78 Malaysia Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 79 Malaysia Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 80 Malaysia Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 81 Rest of Asia Pacific Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 83 Rest of Asia Pacific Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 84 Rest of Asia Pacific Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 85 Rest of Asia Pacific Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 86 Rest of Asia Pacific Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 87 Rest of Asia Pacific Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 88 Rest of Asia Pacific Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Andelyn Biosciences, Inc.
TABLE 90 key information – Charles River Laboratories International, Inc.
TABLE 91 Key Information – Danaher Corporation
TABLE 92 Key Information – FinVector Oy
TABLE 93 Key Information – Thermo Fisher Scientific, Inc.
TABLE 94 Key Information – Novartis AG
TABLE 95 Key Information – Takara Bio Inc.
TABLE 96 Key Information – Avid Bioservices, Inc.
TABLE 97 Key Information – Oxford Biomedica PLC
TABLE 98 Key Information –Lonza Group Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Viral Vector Production Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Viral Vector Production Market
FIG 4 Porter’s Five Forces Analysis – viral vector production market
FIG 5 Asia Pacific Viral Vector Production Market share, by Type, 2022
FIG 6 Asia Pacific Viral Vector Production Market share, by Type, 2030
FIG 7 Asia Pacific Viral Vector Production Market, by Type, 2019 - 2030, USD Million
FIG 8 Asia Pacific Viral Vector Production Market share, by Indication, 2022
FIG 9 Asia Pacific Viral Vector Production Market share, by Indication, 2030
FIG 10 Asia Pacific Viral Vector Production Market, by Indication, 2019 - 2030, USD Millio
FIG 11 Asia Pacific Viral Vector Production Market share, by Application, 2022
FIG 12 Asia Pacific Viral Vector Production Market share, by Application, 2030
FIG 13 Asia Pacific Viral Vector Production Market, by Application, 2019 - 2030, USD Million
FIG 14 Asia Pacific Viral Vector Production Market share, by Country, 2022
FIG 15 Asia Pacific Viral Vector Production Market share, by Country, 2030
FIG 16 Asia Pacific Viral Vector Production Market, by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Andelyn Biosciences, Inc.
FIG 18 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 19 Swot Analysis: Charles River Laboratories International, Inc.
FIG 20 SWOT Analysis: Danaher Corporation
FIG 21 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 22 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Recent strategies and developments: Oxford Biomedica plc
FIG 25 Swot Analysis: Lonza Group Ltd.

Purchase Full Report of
Asia Pacific Viral Vector Production Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL